Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

Cotadutide.

Research draft

Cotadutide is a dual GLP-1 and glucagon receptor agonist.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Cotadutide is a dual GLP-1 and glucagon receptor agonist.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It combines appetite and glucose-related effects with glucagon-mediated metabolic actions.

Human research

Randomised studies investigated diabetes, weight and liver-disease outcomes; trial results are indication-specific.

Preclinical & other research

Metabolic models explored dual-receptor activity.

Safety & unknowns

Gastrointestinal symptoms and metabolic effects require clinical assessment; sustained benefit is not established for every proposed use.

Regulatory status

Clinical research does not establish marketing approval or justify online products.

Reported use & evidence

Research profile draft

The supplied Cotadutide profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds